1Arampatzis C, Goedhart D, Serruys P, et al. On behalf of the LIPS investigators. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention-A Lescol Intervention Prevention Study (LIPS) substudy [ J ]. Am H J, 2005, 149(2) : 329. 被引量：1
2Pasceri V, Patti G, Nusca A, et al. The ARMYDA Investigators randomized trial of atorvastatin for reduction of myo- cardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty ) Study [ J ]. Circulation, 2004, 110 (6) : 674. 被引量：1
3Petronio A, Amoroso G, Limbruno U, et al. Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normoeholesterolemic patients undergoing coron-ary stenting: A randomized study with intravascular ultrasound [J]. Am H J, 2005, 149(3) : 520. 被引量：1
4The post coronary Artery By pass Graft Trial Ingestigation. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenousvein coronary artery bypass grafts. N EngJ Med, 1997, 336(3) : 153. 被引量：1
5Mary E, Charlson O, Wayne Ison. Care after coronary-artery bypass surgery [J]. N Eng Med, 2003, 348 ( 15 ) : 1456. 被引量：1
6Pan W, Pintar T, Anton J, et al. Statins are associated with a reduced incidence of periopera -tive mortality after coronary artery bypass graft surgery. Circulation, 2004, 110 (11): 45. 被引量：1
7Collins R, Armitage J, Parishi S, et al. MRC/BHF Heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial [J]. Lancet, 2003, 361(9374): 2005. 被引量：1
8SommeiJ, MacGillavry M, Meijers J, et al. Anti-Inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes [ J ]. Diabetes care, 2004, 27 (2) : 468. 被引量：1
9Wenket K, Meiser B, Thiery J, et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience [J]. Circulation, 2003, 107(1): 93. 被引量：1
10Sever PS, Dahlof B, Pouher NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm ( ASCOT-LLA ) : a multicentre randomized controlled trial [J]. Lancet, 2003, 361: 1149. 被引量：1
